| Literature DB >> 25990645 |
Raquel Burrows1, Paulina Correa-Burrows1, Marcela Reyes1, Estela Blanco2, Cecilia Albala1, Sheila Gahagan2.
Abstract
OBJECTIVE: To analyse the prevalence of cardiovascular risk factors in healthy adolescents of low to middle socio-economic status and to study the influence of anthropometric, biological and lifestyle factors on the risk of metabolic syndrome (MetS).Entities:
Keywords: Adolescents; Cardiovascular and metabolic risk; Insulin resistance; Metabolic syndrome; Obesity; Sarcopenia
Mesh:
Substances:
Year: 2015 PMID: 25990645 PMCID: PMC4654715 DOI: 10.1017/S1368980015001585
Source DB: PubMed Journal: Public Health Nutr ISSN: 1368-9800 Impact factor: 4.022
Anthropometric, cardiometabolic and lifestyle profile in healthy male and female adolescents aged 16–17 years from Santiago, Chile (n 667)
| Males ( | Females ( | Overall sample ( | ||||
|---|---|---|---|---|---|---|
| Mean or % |
| Mean or % |
| Mean or % |
| |
| Continuous variables (mean and | ||||||
| Age (years) | 16·8 | 0·2 | 16·8* | 0·3 | 16·8 | 0·3 |
| BMI ( | 0·58 | 1·2 | 0·73* | 1·2 | 0·65 | 1·2 |
| WC (cm) | 81·3 | 11·1 | 81·2 | 11·8 | 81·2 | 11·4 |
| Total fat mass (%) | 22·4 | 8·8 | 36·3*** | 7·5 | 29·0 | 10·5 |
| Total fat-free mass (%) | 74·5 | 9·0 | 59·9*** | 7·5 | 67·6 | 10·8 |
| SBP (mmHg) | 115·4 | 10·4 | 108·8*** | 9·7 | 112·2 | 10·6 |
| DBP (mmHg) | 70·8 | 7·0 | 67·6*** | 6·7 | 69·3 | 7·0 |
| Glucose (mg/dl) | 90·4 | 9·6 | 86·5*** | 9·0 | 88·5 | 9·5 |
| Insulin (µUI/ml) | 7·8 | 5·7 | 8·4 | 5·3 | 8·1 | 5·5 |
| HOMA-IR | 1·8 | 1·4 | 1·8 | 1·2 | 1·8 | 1·3 |
| TAG (mg/dl) | 88·4 | 52·4 | 88·2 | 47·6 | 88·3 | 50·2 |
| HDL-C (mg/dl) | 38·0 | 10·1 | 42·5*** | 10·7 | 40·1 | 10·6 |
| hs-CRP (mg/l) | 1·0 | 2·2 | 1·0 | 1·8 | 1·0 | 1·9 |
| Adiponectin (µg/ml) | 10·7 | 5·2 | 13·0*** | 5·6 | 11·8 | 5·5 |
| Physical activity (score) | 5·0 | 2·0 | 3·0*** | 1·0 | 4·0 | 2·0 |
| Food intake (score) | 5·2 | 1·2 | 5·3 | 1·3 | 5·2 | 1·2 |
| Categorical variables (% and 95 % CI) | ||||||
| LGS inflammation | 20·1 | 15·8, 24·3 | 24·1 | 19·4, 29·9 | 22·0 | 18·9, 25·2 |
| Low adiponectin | 24·1 | 19·6, 28·6 | 12·2*** | 8·6, 15·8 | 18·4 | 15·5, 21·4 |
| Insulin resistance | 16·0 | 12·1, 19·9 | 16·6 | 12·5, 20·7 | 16·5 | 13·6, 19·3 |
| Obesity | 15·8 | 11·9, 19·6 | 17·0 | 12·8, 21·2 | 16·1 | 13·4, 19·0 |
| Sarcopenia | 24·9 | 20·4, 29·5 | 25·4 | 20·6, 30·2 | 25·1 | 21·9, 28·4 |
| Physical inactivity | 24·4 | 19·8, 29·0 | 57·9*** | 52·4, 63·3 | 40·8 | 37·0, 44·6 |
| Unhealthy food intake | 23·2 | 18·8, 27·7 | 24·5 | 19·7, 29·2 | 23·8 | 20·6, 27·0 |
WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR; homeostatic model assessment–insulin resistance index; HDL-C, HDL-cholesterol; hs-CRP, high-sensitivity C-reactive protein; LGS, low-grade systemic.
LGS inflammation: hs-CRP ≥75th percentile (hs-CRP≥1·1 mg/l). Low adiponectin: adiponectin ≤25th percentile (adiponectin ≤7·9 µg/ml). Insulin resistance: HOMA-IR ≥2·6. Obesity: BMI Z-score ≥2. Relative sarcopenia: % fat-free mass index ≤25th percentile. Physical inactivity: physical activity score ≤3. Unhealthy food intake: food intake score ≤3·3.
Significant difference between males and females (Student’s t test, Wilcoxon rank-sum test or χ 2 test): *P<0·05, ***P<0·001.
Expressed as median and interquartile range.
Fig. 1Prevalence rates of cardiovascular risk factors and metabolic syndrome (with 95 % confidence intervals represented by vertical bars) among adolescents (n 667) aged 16–17 years (, males; , females; , overall sample) from Santiago, Chile. Significant difference between males and females (Pearson’s χ 2 test): **P<0·01, ***P<0·001
Influence of biological, anthropometric and lifestyle factors (dependent variables) on the risk of metabolic syndrome (independent variable) in healthy male adolescents aged 16–17 years from Santiago, Chile (n 348)
| Adjusted OR | ||||||||
|---|---|---|---|---|---|---|---|---|
| Unadjusted OR | Model 1 | Model 2 | Model 3 | |||||
| Variable | OR | 95 % CI | OR | 95 % CI | OR | 95 % CI | OR | 95 % CI |
| LGS inflammation | 2·65** | 1·26, 5·58 | 3·14** | 1·34, 7·31 | 1·73 | 0·63, 4·78 | 1·65 | 0·58, 4·78 |
| Low adiponectin | 2·65** | 1·28, 5·45 | 1·69 | 0·75, 3·79 | 1·53 | 0·56, 4·15 | 1·59 | 0·57, 4·48 |
| Insulin resistance | 10·26*** | 4·83, 21·8 | 10·37*** | 4·66, 23·1 | 3·20* | 1·20, 8·54 | 3·00* | 1·10, 8·23 |
| Obesity | 28·29*** | 12·1, 66·1 | – | – | 3·42* | 1·23, 9·51 | 3·74* | 1·23, 10·8 |
| Relative sarcopenia | 79·13*** | 18·4, 339·8 | – | – | 25·9*** | 5·22, 128·9 | 21·2*** | 4·18, 107·5 |
| Physical inactivity | 4·91*** | 2·38, 10·1 | – | – | – | – | 2·94* | 1·12, 7·72 |
| Unhealthy food intake | 0·82 | 0·34, 1·96 | – | – | – | – | – | – |
| Likelihood ratio ( | 44·95*** | 107·1*** | 112·0*** | |||||
| Hosmer–Lemeshow | 6·20 ( | 5·34 ( | 5·33 ( | |||||
| Correctly classified (%) | 89·7 | 91·1 | 92·5 | |||||
LGS, low-grade systemic; –; non-observed; hs-CRP, high-sensitivity C-reactive protein; HOMA-IR; homeostatic model assessment–insulin resistance index.
Model 1, biological variables; model 2, model 1 plus anthropometric variables; model 3, model 2 plus lifestyle factors.
LGS inflammation: hs-CRP ≥75th percentile (hs-CRP≥1·1 mg/l). Low adiponectin: adiponectin ≤25th percentile (adiponectin≤7·9 µg/ml). Insulin resistance: HOMA-IR ≥2·6. Obesity: BMI Z-score ≥2. Relative sarcopenia: % fat-free mass index ≤25th percentile. Physical inactivity: physical activity score ≤3. Unhealthy food intake: food index score ≤3·3.
Statistical significance: *P<0·05, **P<0·01, ***P<0·001.
Influence of biological, anthropometric and lifestyle factors (dependent variables) on the risk of metabolic syndrome (independent variable) in healthy female adolescents aged 16–17 years from Santiago, Chile (n 348)
| Adjusted OR | ||||||||
|---|---|---|---|---|---|---|---|---|
| Unadjusted OR | Model 1 | Model 2 | Model 3 | |||||
| Variable | OR | 95 % CI | OR | 95 % CI | OR | 95 % CI | OR | 95 % CI |
| LGS inflammation | 1·55 | 0·67, 3·59 | – | – | – | – | – | – |
| Low adiponectin | 3·35** | 1·36, 8·25 | 2·46 | 0·92, 6·58 | 1·86 | 0·63, 5·50 | 1·78 | 0·59, 5·39 |
| Insulin resistance | 9·15*** | 4·01, 20·9 | 8·31*** | 3·60, 19·2 | 4·90*** | 1·94, 12·4 | 4·96** | 1·95, 12·6 |
| Obesity | 11·0*** | 4·75, 25·0 | – | – | 2·85 | 0·86, 9·43 | 2·64 | 0·81, 8·62 |
| Relative sarcopenia | 9·40*** | 3·96, 22·4 | – | – | 3·50* | 1·05, 11·7 | 3·61* | 1·10, 11·9 |
| Physical inactivity | 2·92* | 1·15, 7·41 | – | – | – | – | 2·44 | 0·87, 6·88 |
| Unhealthy food intake | 1·04 | 0·42, 2·53 | – | – | – | – | – | – |
| Likelihood ratio ( | 29·96*** | 50·7*** | 53·8*** | |||||
| Hosmer–Lemeshow | 6·20 ( | 2·51 ( | 5·76 ( | |||||
| Correctly classified (%) | 91·2 | 92·2 | 92·2 | |||||
LGS, low-grade systemic; –, non-observed; hs-CRP, high-sensitivity C-reactive protein; HOMA-IR; homeostatic model assessment–insulin resistance index.
Model 1, biological variables; model 2, model 1 plus anthropometric variables; model 3, model 2 plus lifestyle factors.
LGS inflammation: hs-CRP ≥75th percentile (hs-CRP≥1·1 mg/l). Low adiponectin: adiponectin ≤25th percentile (adiponectin≤7·9 µg/ml). Insulin resistance: HOMA-IR ≥2·6. Obesity: BMI Z-score ≥2. Relative sarcopenia: % fat-free mass index ≤25th percentile. Physical inactivity: physical activity score ≤3. Unhealthy food intake: food index score ≤3·3.
Statistical significance: *P<0·05, **P<0·01, ***P<0·001.